Andrew M. Oh - Net Worth and Insider Trading

Andrew M. Oh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew M. Oh owns 2 companies in total, including Rubius Therapeutics Inc (RUBY) , and Syros Pharmaceuticals Inc (SYRS) .

Click here to see the complete history of Andrew M. Oh’s form 4 insider trades.

Insider Ownership Summary of Andrew M. Oh

Ticker Comapny Transaction Date Type of Owner
RUBY Rubius Therapeutics Inc 2018-07-17 Chief Financial Officer
SYRS Syros Pharmaceuticals Inc 2022-09-16 director

Andrew M. Oh Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrew M. Oh Ownership Network

Ownership Network List of Andrew M. Oh

No Data

Ownership Network Relation of Andrew M. Oh

Insider Network Chart

Andrew M. Oh Owned Company Details

What does Rubius Therapeutics Inc do?

Who are the key executives at Rubius Therapeutics Inc?

Andrew M. Oh is the Chief Financial Officer of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .

Rubius Therapeutics Inc (RUBY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rubius Therapeutics Inc Insider Transactions

No Available Data

Andrew M. Oh Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew M. Oh. You might contact Andrew M. Oh via mailing address: C/o Rubius Therapeutics, 325 Vassar St., Ste. 1a, Cambridge Ma 02139.